-+ 0.00%
-+ 0.00%
-+ 0.00%

JMP Securities Reiterates Market Outperform on Benitec Biopharma, Maintains $20 Price Target

Benzinga·05/15/2025 13:45:53
Listen to the news
JMP Securities analyst Silvan Tuerkcan reiterates Benitec Biopharma (NASDAQ:BNTC) with a Market Outperform and maintains $20 price target.